Literature DB >> 20847213

t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not.

Albert G Tsai, Akinori Yoda, David M Weinstock, Michael R Lieber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20847213      PMCID： PMC5773278          DOI： 10.1182/blood-2010-05-286492

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/API2-MALT1 translocation in MALT lymphomas is not.

Authors:  Albert G Tsai; Zhengfei Lu; Michael R Lieber
Journal:  Blood       Date:  2010-04-29       Impact factor: 22.113

2.  Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.

Authors:  Albert G Tsai; Haihui Lu; Sathees C Raghavan; Markus Muschen; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

3.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Authors:  Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffrey L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

4.  Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

Authors:  Libi Hertzberg; Elena Vendramini; Ithamar Ganmore; Gianni Cazzaniga; Maike Schmitz; Jane Chalker; Ruth Shiloh; Ilaria Iacobucci; Chen Shochat; Sharon Zeligson; Gunnar Cario; Martin Stanulla; Sabine Strehl; Lisa J Russell; Christine J Harrison; Beat Bornhauser; Akinori Yoda; Gideon Rechavi; Dani Bercovich; Arndt Borkhardt; Helena Kempski; Geertruy te Kronnie; Jean-Pierre Bourquin; Eytan Domany; Shai Izraeli
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

5.  Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; J Racquel Collins-Underwood; Letha A A Phillips; Michael G Loudin; Wei Liu; Jinghui Zhang; Jing Ma; Elaine Coustan-Smith; Richard C Harvey; Cheryl L Willman; Fady M Mikhail; Julia Meyer; Andrew J Carroll; Richard T Williams; Jinjun Cheng; Nyla A Heerema; Giuseppe Basso; Andrea Pession; Ching-Hon Pui; Susana C Raimondi; Stephen P Hunger; James R Downing; William L Carroll; Karen R Rabin
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

6.  Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

Authors:  Lisa J Russell; Melania Capasso; Inga Vater; Takashi Akasaka; Olivier A Bernard; Maria Jose Calasanz; Thiruppavaii Chandrasekaran; Elise Chapiro; Stephan Gesk; Mike Griffiths; David S Guttery; Claudia Haferlach; Lana Harder; Olaf Heidenreich; Julie Irving; Lyndal Kearney; Florence Nguyen-Khac; Lee Machado; Lynne Minto; Aneela Majid; Anthony V Moorman; Heather Morrison; Vikki Rand; Jonathan C Strefford; Claire Schwab; Holger Tönnies; Martin J S Dyer; Reiner Siebert; Christine J Harrison
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113
  6 in total
  11 in total

1.  Mechanism of fragility at BCL2 gene minor breakpoint cluster region during t(14;18) chromosomal translocation.

Authors:  Mridula Nambiar; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Human lymphoid translocation fragile zones are hypomethylated and have accessible chromatin.

Authors:  Zhengfei Lu; Michael R Lieber; Albert G Tsai; Carolina E Pardo; Markus Müschen; Michael P Kladde; Chih-Lin Hsieh
Journal:  Mol Cell Biol       Date:  2015-01-26       Impact factor: 4.272

3.  TSLP signaling network revealed by SILAC-based phosphoproteomics.

Authors:  Jun Zhong; Min-Sik Kim; Raghothama Chaerkady; Xinyan Wu; Tai-Chung Huang; Derese Getnet; Christopher J Mitchell; Shyam M Palapetta; Jyoti Sharma; Robert N O'Meally; Robert N Cole; Akinori Yoda; Albrecht Moritz; Marc M Loriaux; John Rush; David M Weinstock; Jeffrey W Tyner; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2012-02-16       Impact factor: 5.911

4.  BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements.

Authors:  Zhengfei Lu; Albert G Tsai; Takashi Akasaka; Hitoshi Ohno; Yanwen Jiang; Ari M Melnick; Harvey A Greisman; Michael R Lieber
Journal:  Blood       Date:  2013-03-08       Impact factor: 22.113

5.  Both CpG methylation and activation-induced deaminase are required for the fragility of the human bcl-2 major breakpoint region: implications for the timing of the breaks in the t(14;18) translocation.

Authors:  Xiaoping Cui; Zhengfei Lu; Aya Kurosawa; Lars Klemm; Andrew T Bagshaw; Albert G Tsai; Neil Gemmell; Markus Müschen; Noritaka Adachi; Chih-Lin Hsieh; Michael R Lieber
Journal:  Mol Cell Biol       Date:  2012-12-21       Impact factor: 4.272

Review 6.  Mechanisms of human lymphoid chromosomal translocations.

Authors:  Michael R Lieber
Journal:  Nat Rev Cancer       Date:  2016-05-25       Impact factor: 60.716

7.  Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.

Authors:  C Vesely; C Frech; C Eckert; G Cario; A Mecklenbräuker; U Zur Stadt; K Nebral; F Kraler; S Fischer; A Attarbaschi; M Schuster; C Bock; H Cavé; A von Stackelberg; M Schrappe; M A Horstmann; G Mann; O A Haas; R Panzer-Grümayer
Journal:  Leukemia       Date:  2016-11-30       Impact factor: 11.528

8.  Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.

Authors:  Maria Morak; Andishe Attarbaschi; Susanna Fischer; Christine Nassimbeni; Reinhard Grausenburger; Stephan Bastelberger; Stefanie Krentz; Gunnar Cario; David Kasper; Klaus Schmitt; Lisa J Russell; Ulrike Pötschger; Martin Stanulla; Conny Eckert; Georg Mann; Oskar A Haas; Renate Panzer-Grümayer
Journal:  Blood       Date:  2012-10-22       Impact factor: 22.113

9.  TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.

Authors:  Jun Zhong; Jyoti Sharma; Rajesh Raju; Shyam Mohan Palapetta; T S Keshava Prasad; Tai-Chung Huang; Akinori Yoda; Jeffrey W Tyner; Diederik van Bodegom; David M Weinstock; Steven F Ziegler; Akhilesh Pandey
Journal:  Database (Oxford)       Date:  2014-02-25       Impact factor: 3.451

10.  Mechanistic basis for chromosomal translocations at the E2A gene and its broader relevance to human B cell malignancies.

Authors:  Di Liu; Yong-Hwee Eddie Loh; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell Rep       Date:  2021-07-13       Impact factor: 9.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.